The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125980555 12598055 5 F 2016 20160915 20160727 20160923 EXP PL-TAKEDA-2016MPI006578 TAKEDA 80.00 YR F Y 63.00000 KG 20160923 MD PL PL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125980555 12598055 1 PS VELCADE BORTEZOMIB 1 Subcutaneous 2.2 MG, 1/WEEK 4371089 21602 2.2 MG INJECTION /wk
125980555 12598055 2 SS PREDNISONE. PREDNISONE 1 Oral 100 MG, UNK 4370217 0 100 MG
125980555 12598055 3 SS PREDNISONE. PREDNISONE 1 Oral 100 MG, UNK 4370217 0 100 MG
125980555 12598055 4 SS PREDNISONE. PREDNISONE 1 Oral 100 MG, UNK 4370217 0 100 MG
125980555 12598055 5 SS DARATUMUMAB DARATUMUMAB 1 Intravenous (not otherwise specified) 1008 MG, UNK EKTKO;4371374 0 1008 MG
125980555 12598055 6 SS MELPHALAN MELPHALAN 1 Oral 14 MG, UNK 437136 0 14 MG
125980555 12598055 7 SS MELPHALAN MELPHALAN 1 Oral 14 MG, UNK 437136 0 14 MG
125980555 12598055 8 SS MELPHALAN MELPHALAN 1 Oral 14 MG, UNK 437136 0 14 MG
125980555 12598055 9 C POLOCARD ASPIRIN 1 Oral 150 MG, QD D 0 150 MG TABLET QD
125980555 12598055 10 C EGIRAMLON 2 Oral 10 MG, QD D 0 10 MG TABLET QD
125980555 12598055 11 C BETO ZK METOPROLOL SUCCINATE 1 Oral 142.5 MG, QD D 0 142.5 MG TABLET QD
125980555 12598055 12 C EFFOX ISOSORBIDE MONONITRATE 1 Oral 50 MG, QD D 0 50 MG TABLET QD
125980555 12598055 13 C LETROX LEVOTHYROXINE SODIUM 1 Oral 100 ?G, QD D 0 100 UG TABLET QD
125980555 12598055 14 C AVAMINA 2 Oral 850 MG, QD D 0 850 MG TABLET QD
125980555 12598055 15 C HEVIRAN /00587301/ 2 Oral 400 MG, BID D 0 400 MG TABLET BID
125980555 12598055 16 C CONTROLOC /01263201/ 2 Oral 0.02 MG, BID 640 MG D 0 .02 MG CAPSULE BID
125980555 12598055 17 C BISEPTOL SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 480 MG, BID 24000 MG D 0 480 MG TABLET BID
125980555 12598055 18 C GRANULOCYTE COLONY STIMULATING FACTOR GRANULOCYTE COLONY-STIMULATING FACTOR NOS 1 Subcutaneous 0.5 ML, QD D 0 .5 ML INJECTION QD
125980555 12598055 19 C GASEC 2 Oral 20 MG, QD D 0 20 MG TABLET QD
125980555 12598055 20 C GASEC 2 Oral 20 MG, UNK D 0 20 MG TABLET
125980555 12598055 21 C GASEC 2 Oral 20 MG, BID D 0 20 MG TABLET BID
125980555 12598055 22 C DICLOFENACUM NATRICUM 2 Intramuscular 75 MG, QD D 0 75 MG INJECTION QD
125980555 12598055 23 C KETOPROFEN. KETOPROFEN 1 Unknown 0.1 G, QD D 0 .1 G COATED TABLET QD
125980555 12598055 24 C TRAMAL TRAMADOL 1 Unknown 0.05 G, BID D 0 .05 G TABLET BID
125980555 12598055 25 C ACECLOFENACUM 2 Oral 100 MG, QD D 0 100 MG QD
125980555 12598055 26 C MYDOCALM FORTE 2 Oral 150 MG, BID D 0 150 MG BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125980555 12598055 1 Plasma cell myeloma
125980555 12598055 2 Plasma cell myeloma
125980555 12598055 5 Plasma cell myeloma
125980555 12598055 6 Plasma cell myeloma
125980555 12598055 9 Antiplatelet therapy
125980555 12598055 10 Hypertension
125980555 12598055 11 Hypertension
125980555 12598055 12 Hypertension
125980555 12598055 13 Hypothyroidism
125980555 12598055 14 Type 2 diabetes mellitus
125980555 12598055 15 Infection prophylaxis
125980555 12598055 16 Gastrointestinal disorder therapy
125980555 12598055 17 Infection prophylaxis
125980555 12598055 18 Neutropenia
125980555 12598055 19 Gastrointestinal disorder therapy
125980555 12598055 22 Arthralgia
125980555 12598055 25 Sciatica
125980555 12598055 26 Sciatica

Outcome of event

Event ID CASEID OUTC COD
125980555 12598055 OT
125980555 12598055 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
125980555 12598055 Intervertebral disc disorder
125980555 12598055 Neutropenia
125980555 12598055 Paraparesis
125980555 12598055 Polyneuropathy
125980555 12598055 Rash

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125980555 12598055 1 20160315 0
125980555 12598055 2 20160315 20160318 0
125980555 12598055 3 20160427 20160429 0
125980555 12598055 4 20160608 20160610 0
125980555 12598055 5 20160315 0
125980555 12598055 6 20160315 20160318 0
125980555 12598055 7 20160426 20160429 0
125980555 12598055 8 20160607 20160610 0
125980555 12598055 9 2012 0
125980555 12598055 10 2013 0
125980555 12598055 11 2013 0
125980555 12598055 12 2013 0
125980555 12598055 13 2012 0
125980555 12598055 14 2014 0
125980555 12598055 15 20160315 0
125980555 12598055 16 20160315 20160322 0
125980555 12598055 17 20160315 20160408 0
125980555 12598055 18 20160329 20160402 0
125980555 12598055 19 20160322 20160429 0
125980555 12598055 20 20160517 20160517 0
125980555 12598055 21 20160607 20160610 0
125980555 12598055 22 20160519 0
125980555 12598055 25 20160530 0
125980555 12598055 26 20160530 0

Execution Time: 0.0079009532928467 seconds (ucode:5106365). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.